US EditionImprovements In Prostate Cancer Tracking Help Men Stay In Active Surveillance
- Data from 869 participants enrolled in UCLA’s active surveillance program from 2010 to 2022 were examined to evaluate enhancements in monitoring prostate cancer.
- They tested whether advanced MRI-guided biopsies and focal therapies could make active surveillance safer and more effective for low- to medium-risk prostate cancer.
- MRI accurately identified stable tumors in 90% to 95% of men, reducing repeat biopsies, while about a quarter received focal therapy to treat slightly higher-risk cases.
- Dr. Leonard Marks emphasized that integrating MRI-based diagnostics with targeted focal treatments provides a tailored option for patients, enabling more precise tumor monitoring and reducing the need for unnecessary interventions.
- The study indicates that incorporating advanced imaging and minimally invasive therapies enables more men with low-risk prostate cancer to safely extend the period of active monitoring while maintaining their quality of life.
Insights by Ground AI
Does this summary seem wrong?
21 Articles
21 Articles
All
Left
4
Center
5
Right
3
InsideNoVA.com+17 Reposted by 17 other sources
Improvements In Prostate Cancer Tracking Help Men Stay In Active Surveillance
Key Takeaways
Coverage Details
Total News Sources21
Leaning Left4Leaning Right3Center5Last UpdatedBias Distribution42% Center
Bias Distribution
- 42% of the sources are Center
42% Center
L 33%
C 42%
R 25%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
